Journal of Shanghai Jiao Tong University (Medical Science) >

2021 , Vol. 41 >Issue 12: 1677 - 1682

DOI: https://doi.org/10.3969/j.issn.1674-8115.2021.12.019

Public health

Health-related quality of life and its influencing factors among patients with gastroesophageal reflux disease

  • Zi-yun GAO ,
  • Yu-qing YAN ,
  • Tian-ying TONG ,
  • Li-jun NING ,
  • Jie HONG ,
  • Zhen-hua WANG
Expand
  • Department of Gastroenterology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200001, China
WANG Zhen-hua, E-mail: zhenhuawang@126.com. #Co-corresponding author.
HONG Jie, E-mail: jiehong97@sjtu.edu.cn

Received date: 2021-05-26

  Online published: 2021-01-28

Supported by

Shanghai Municipal Education Commission—Gaofeng Clinical Medicine Grant Support(20152512)

Fold

Abstract

Objective

·To evaluate the health-related quality of life (HRQoL) of patients with gastroesophageal reflux disease (GERD), and to explore the related factors.

Methods

·EuroQol 5-Dimensions Instrument with 5-Level Scale (EQ-5D-5L) questionnaire was conducted on 108 GERD patients who visited the Gastroenterology Clinic of Renji Hospital, Shanghai Jiao Tong University School of Medicine from May to December 2019. GERD-Q questionnaire was used to assess their clinical symptoms. Other data including sociodemographic characteristics, disease-related information and medical costs were collected at the same time. Fisher's exact test was used to compare the amount and proportion of patients who had health problems in each dimension. The univariate Tobit model was used to select the influencing factors that were correlated with the EQ-5D-5L utility. Multivariate regression analysis such as the ordinary least squares (OLS) and Logistic regression model were employed to explore the factors affecting HRQoL of GERD patients.

Results

·In the 108 patients, the average EQ-5D-5L utility score was 0.855 with a standard deviation (SD) of 0.162. In the subgroups of body mass index (BMI) (P=0.000), gender (P=0.000), endoscopy grade (P=0.000), GERD-Q score (P=0.049), medication and medical expenditures (P=0.000), the difference of proportion of patients who reported they had health problem were statistically significant. In OLS model, GERD-Q score greater than/equal to 8 and the higher medical expenditure had a negative impact on HRQoL (P<0.05), while use of antacids had a positive effect (P<0.05). Logistic regression analysis indicated that disease duration (OR=1.222, P=0.050) and use of antacids (OR=10.808, P=0.044) had positive relationship with HRQoL.

Conclusion

·GERD could decrease the HRQoL of patients, and it requires the support and attention of medical decision-makers.

Key words： gastroesophageal reflux disease (GERD); EuroQol 5-Dimensions Instrument with 5-Level Scale (EQ-5D-5L); health-related quality of life (HRQoL)

Cite this article

Zi-yun GAO , Yu-qing YAN , Tian-ying TONG , Li-jun NING , Jie HONG , Zhen-hua WANG . Health-related quality of life and its influencing factors among patients with gastroesophageal reflux disease[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2021 , 41(12) : 1677 -1682 . DOI: 10.3969/j.issn.1674-8115.2021.12.019

References

1 Maret-Ouda J, Markar SR, Lagergren J. Gastroesophageal reflux disease: a review[J]. JAMA, 2020, 324(24): 2536-2547.
2 Nirwan JS, Hasan SS, Babar ZU, et al. Global prevalence and risk factors of gastro-oesophageal reflux disease (GORD): systematic review with meta-analysis[J]. Sci Rep, 2020, 10(1): 5814.
3 Mason J, Hungin AP. Review article: gastro-oesophageal reflux disease: the health economic implications[J]. Aliment Pharmacol Ther, 2005, 22(): 20-31.
4 Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States[J]. Gastroenterology, 2002, 122(5): 1500-1511.
5 Wiklund I. Review of the quality of life and burden of illness in gastroesophageal reflux disease[J]. Dig Dis Basel Switz, 2004, 22(2): 108-114.
6 Devlin NJ, Brooks R. EQ-5D and the EuroQol Group: past, present and future[J]. Appl Health Econ Health Policy, 2017, 15(2): 127-137.
7 Kahrilas PJ, Shaheen NJ, Vaezi MF. American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease[J]. Gastroenterology, 2008, 135(4): 1383-1391.e5.
8 Luo N, Liu G, Li M, et al. Estimating an EQ-5D-5L value set for China[J]. Value Health, 2017, 20(4): 662-669.
9 Jones R, Junghard O, Dent J, et al. Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care[J]. Aliment Pharmacol Ther, 2009, 30(10): 1030-1038.
10 Armstrong D, Bennett JR, Blum AL, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement[J]. Gastroenterology, 1996, 111(1): 85-92.
11 Yang ZH, Busschbach J, Liu G, et al. EQ-5D-5L norms for the urban Chinese population in China[J]. Heal Qual Life Outcomes, 2018, 16(1): 210.
12 Chen M, Xiong L, Chen H, et al. Prevalence, risk factors and impact of gastroesophageal reflux disease symptoms: a population-based study in South China[J]. Scand J Gastroenterol, 2005, 40(7): 759-767.
13 Wang R, Wang J, Hu S. Study on the relationship of depression, anxiety, lifestyle and eating habits with the severity of reflux esophagitis[J]. BMC Gastroenterol, 2021, 21(1): 127.
14 Ofman JJ. The economic and quality-of-life impact of symptomatic gastroesophageal reflux disease[J]. Am J Gastroenterol, 2003, 98(3): S8-S14.
15 Eusebi LH, Ratnakumaran R, Yuan Y, et al. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis[J]. Gut, 2018, 67(3): 430-440.
16 Jacobson BC, Somers SC, Fuchs CS, et al. Body-mass index and symptoms of gastroesophageal reflux in women[J]. New Engl J Med, 2006, 354(22): 2340-2348.
17 Kohata Y, Fujiwara Y, Watanabe T, et al. Long-term benefits of smoking cessation on gastroesophageal reflux disease and health-related quality of life[J]. PLoS One, 2016, 11(2): e0147860.
18 Eslick GD, Talley NJ. Gastroesophageal reflux disease (GERD): risk factors, and impact on quality of life-a population-based study[J]. J Clin Gastroenterol, 2009, 43(2): 111-117.
19 Lee SW, Chang CM, Chang CS, et al. Comparison of presentation and impact on quality of life of gastroesophageal reflux disease between young and old adults in a Chinese population[J]. World J Gastroenterol, 2011, 17(41): 4614-4618.
20 Hongo M, Miwa H, Kusano M, et al. Symptoms and quality of life in underweight gastroesophageal reflux disease patients and therapeutic responses to proton pump inhibitors[J]. J Gastroenterol Hepatol, 2012, 27(5): 913-918.
21 Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease[J]. Am J Gastroenterol, 2013, 108(3): 308-328.
Options
Outlines

/

〈 〉